Clinical trials recruiting for HER2/Neu Negative
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cediranib | 1 |
| Ceralasertib | 1 |
| Olaparib | 1 |
| Partial Breast Irradiation | 1 |
| Undergo EBRT | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| Arizona | 2 |
| Florida | 2 |
| Hawaii | 2 |
| Minnesota | 2 |
| New Jersey | 2 |
| North Carolina | 2 |
| Pennsylvania | 2 |
| Alaska | 1 |
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
Top cities
Self-screener
Recruiting trials
- Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Related conditions
Trials recruiting for HER2/Neu Negative often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HER2/Neu Negative trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.